110 related articles for article (PubMed ID: 21439515)
1. Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: a matched case-control study.
Chang HJ; Hsu PC; Yang CC; Kuo AJ; Chia JH; Wu TL; Lee MH
J Microbiol Immunol Infect; 2011 Apr; 44(2):125-30. PubMed ID: 21439515
[TBL] [Abstract][Full Text] [Related]
2. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Huang SS; Lee MH; Leu HS
J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study.
Liu SW; Chang HJ; Chia JH; Kuo AJ; Wu TL; Lee MH
J Microbiol Immunol Infect; 2012 Apr; 45(2):113-9. PubMed ID: 22154994
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Metan G; Zarakolu P; Cakir B; Hascelik G; Uzun O
Int J Antimicrob Agents; 2005 Sep; 26(3):254-7. PubMed ID: 16122910
[TBL] [Abstract][Full Text] [Related]
5. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance.
Berger J; Diab-Elschahawi M; Blacky A; Pernicka E; Spertini V; Assadian O; Koller W; Aichberger KJ
Am J Infect Control; 2010 Dec; 38(10):839-45. PubMed ID: 20650546
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients.
Jeon MH; Choi SH; Kwak YG; Chung JW; Lee SO; Jeong JY; Woo JH; Kim YS
Diagn Microbiol Infect Dis; 2008 Dec; 62(4):402-6. PubMed ID: 18993012
[TBL] [Abstract][Full Text] [Related]
7. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
8. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study.
Ahn JY; Song JE; Kim MH; Choi H; Kim JK; Ann HW; Kim JH; Jeon Y; Jeong SJ; Kim SB; Ku NS; Han SH; Song YG; Yong D; Lee K; Kim JM; Choi JY
Am J Infect Control; 2014 Jun; 42(6):621-5. PubMed ID: 24837112
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
[TBL] [Abstract][Full Text] [Related]
11. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
[TBL] [Abstract][Full Text] [Related]
12. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
[TBL] [Abstract][Full Text] [Related]
13. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A;
Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
Kim YA; Choi JY; Kim CK; Kim CO; Kim MS; Choi SH; Chin BS; Han SH; Lee HS; Choi HK; Jeoung SJ; Song YG; Yum JH; Yong D; Lee K; Kim JM
Scand J Infect Dis; 2008; 40(3):234-40. PubMed ID: 17852898
[TBL] [Abstract][Full Text] [Related]
15. Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection.
Suárez C; Peña C; Gavaldà L; Tubau F; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e73-8. PubMed ID: 20223693
[TBL] [Abstract][Full Text] [Related]
16. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
[TBL] [Abstract][Full Text] [Related]
17. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
Bin C; Hui W; Renyuan Z; Yongzhong N; Xiuli X; Yingchun X; Yuanjue Z; Minjun C
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):351-7. PubMed ID: 16934430
[TBL] [Abstract][Full Text] [Related]
18. Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program.
Bhavnani SM; Ambrose PG; Craig WA; Dudley MN; Jones RN;
Diagn Microbiol Infect Dis; 2006 Mar; 54(3):231-6. PubMed ID: 16423491
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India.
Abhilash KP; Veeraraghavan B; Abraham OC
J Assoc Physicians India; 2010 Dec; 58 Suppl():13-7. PubMed ID: 21563608
[TBL] [Abstract][Full Text] [Related]
20. Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter?
Tuon FF; Rymsza AM; Penteado-Filho SR; Pilonetto M; Arend LN; Levin AS
J Infect; 2011 Mar; 62(3):246-9. PubMed ID: 21256151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
